CTOs on the Move

Oculus Innovative Sciences, Inc.

www.oculusis.com

 
Oculus Innovative Sciences, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oculusis.com
  • 1129 N Mcdowell Blvd
    Petaluma, CA USA 94954
  • Phone: 707.283.0550

Executives

Name Title Contact Details

Similar Companies

Halcyon Rehabilitation

Halcyon Rehabilitation enhances the quality of life in the community we service through top tier Physical Therapy, Occupational Therapy and Speech Language Pathology focused on long term care facilities. Our population focused programs allow us to assi...

Mississippi Sports Medicine

Mississippis first full-service orthopaedic speciality practice. #AnyAge #AnySport #AnyInjury Just come here; weve got you covered.

OVP HEALTH

HEALTHIER. COMMUNITY. OVP HEALTH provides an extensive range of addiction treatment services, emergency department and hospitalist staffing and management services.

AnkaBehavioralHealth

All of Ankas programs share the same mission: to eliminate the impact of behavioral health problems for all people.

Mirum Pharmaceuticals

Mirum Pharmaceuticals (NASDAQ: MIRM) is dedicated to creating life-changing therapies for patients with liver diseases. We are advancing our lead product candidate for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC) — conditions with a profound and devastating impact on quality of life for young patients and their families. Untreated, these conditions can lead to liver failure and inflict life-altering symptoms including stunted growth and severe, non-stop itching. Under current standard of care, patients often require a liver transplant and are at higher risk of many serious health issues. Working closely with patients and caregiver communities, we intimately understand the challenges of living with cholestatic liver diseases. Based on a wealth of data from clinical trials spanning multiple years and involving more than one hundred patients, we believe our approach can address the underlying cause of symptoms and liver damage. Our goal is to give families their lives back.